Article (Scientific journals)
Activation and coagulation biomarkers are independent predictors of the development of opportunistic disease in patients with HIV infection.
Rodger, Alison J; Fox, Zoe; Lundgren, Jens D et al.
2009In Journal of Infectious Diseases, 200 (6), p. 973-83
Peer Reviewed verified by ORBi
 

Files


Full Text
nihms206143.pdf
Author postprint (446.76 kB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
AIDS-Related Opportunistic Infections/metabolism; Adult; Anti-HIV Agents; Biological Markers; Blood Coagulation/physiology; C-Reactive Protein/metabolism; Case-Control Studies; Female; Humans; Inflammation/metabolism; Interleukin-6/metabolism; Male; Middle Aged; Odds Ratio; Risk Factors; Serum Amyloid A Protein/metabolism; Serum Amyloid P-Component/metabolism
Abstract :
[en] BACKGROUND: Activation and coagulation biomarkers were measured within the Strategies for Management of Antiretroviral Therapy (SMART) trial. Their associations with opportunistic disease (OD) in human immunodeficiency virus (HIV)-positive patients were examined. METHODS: Inflammatory (high-sensitivity C-reactive protein [hsCRP], interleukin-6 [IL-6], amyloid-A, and amyloid-P) and coagulation (D-dimer and prothrombin-fragment 1+2) markers were determined. Conditional logistic regression analyses were used to assess associations between these biomarkers and risk of OD. RESULTS: The 91 patients who developed an OD were matched to 182 control subjects. Patients with an hsCRP level > or =5 microg/mL at baseline had a 3.5 higher odds of OD (95% confidence interval [CI], 1.5-8.1) than did those with an hsCRP level <1 microg/mL (P=.003, by test for trend) and patients with an IL-6 level > or =3 pg/mL at baseline had a 2.4 higher odds of OD (95% CI, 1.0-5.4) than did those with an IL-6 level <1.5 pg/mL (P=.02, by test for trend). No other baseline biomarkers predicted development of an OD. Latest follow-up hsCRP level for those with an hsCRP level > or =5 microg/mL (compared with a level <1 microg/mL; odds ratio [OR], 7.6; 95% CI, 2.0-28.5; [P=.002, by test for trend), latest amyloid-A level for those with an amyloid-A level > or =6 mg/L (compared with a level <2 mg/L; OR, 3.8; 95% CI, 1.1-13.4; P=.03, by test for trend), and latest IL-6 level for those with an IL-6 level > or =3 pg/mL (compared with a level <1.5 pg/mL; OR 2.4; 95% CI, 0.7-8.8; P=.04, by test for trend) were also associated with development of an OD. CONCLUSIONS: Higher IL-6 and hsCRP levels independently predicted development of OD. These biomarkers could provide additional prognostic information for predicting the risk of OD.
Disciplines :
Immunology & infectious disease
Author, co-author :
Rodger, Alison J
Fox, Zoe
Lundgren, Jens D
Kuller, Lewis H
Boesecke, Christoph
Gey, Daniela
Skoutelis, Athanassios
Goetz, Matthew Bidwell
Phillips, Andrew N
Other collaborator :
Moutschen, Michel  ;  Université de Liège - ULiège > Département des sciences cliniques > GIGA-R:Immunopath. - Maladies infect. et médec. inter. gén.
Language :
English
Title :
Activation and coagulation biomarkers are independent predictors of the development of opportunistic disease in patients with HIV infection.
Publication date :
2009
Journal title :
Journal of Infectious Diseases
ISSN :
0022-1899
eISSN :
1537-6613
Publisher :
University of Chicago Press, Chicago, United States - Illinois
Volume :
200
Issue :
6
Pages :
973-83
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 04 September 2010

Statistics


Number of views
92 (2 by ULiège)
Number of downloads
180 (0 by ULiège)

Scopus citations®
 
132
Scopus citations®
without self-citations
124
OpenCitations
 
113

Bibliography


Similar publications



Contact ORBi